Survival in prostate cancer patients ≥70 years after radical prostatectomy and comparison to younger patients

World Journal of Urology

Volumn 27, Issue 5, 2009, Pages 637-642

  Pfitzenmaier, Jesco ^a   Pahernik, Sascha ^a   Buse, Stephan ^a   Haferkamp, Axel ^a   Djakovic, Nenad ^a   Hohenfellner, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clinical outcome; Elderly; Prostate cancer; PSA; PSA free survival; Radical prostatectomy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMPARATIVE STUDY; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 70349488845     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0414-0     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al (2008) Cancer statistics. CA Cancer J Clin 58(2):71-96
2. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. CA Cancer J Clin 47(1):5-27
3. Pienta KJ (1997) Etiology, epidemiology, and prevention of carcinoma of the prostate. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell's urology, 7th edn, chap 80. Saunders, Philadelphia, pp 2489-2496
4. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28(3):555-565
5. Lepor H (2001) Radical retropubic prostatectomy. Urol Clin North Am 28(3):509-519, viii
6. Marien TP, Lepor H (2008) Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy? BJU Int
7. Lepor H, Kozirovsky M, Laze J, Telegrafi S (2008) Transabdominal sonocystography: A novel technique to assess vesicourethral extravasation following radical prostatectomy. J Urol 180(6):2459-2462
8. Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O et al (2008) Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71(4):1028-1033
9. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H (1996) Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 156(1):137-143
10. Pfitzenmaier J, Vessella RL, Ellis WJ, Lange PH (2003) Detection, isolation, and study of disseminated prostate cancer cells in the peripheral blood and bone marrow. In: Pantel K (ed) 1st edn, chap 5. Kluwer, Dordrecht, pp 87-116
11. Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M (2008) Positive surgical margins after radical prostatectomy: Do they have an impact on biochemical or clinical progression? BJU Int 102(10):1413-1418
12. Burkhard FC, Studer UE (2008) The role of lymphadenectomy in high risk prostate cancer. World J Urol 26(3):231-236
13. Klotz L (2008) Active surveillance for prostate cancer: Trials and tribulations. World J Urol 26(5):437-442
14. Jeldres C, Suardi N, Walz J, Saad F, Hutterer GC, Bhojani N et al (2008) Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men. Eur Urol 54(1):107-116
15. Bott SR, Kirby RS (2002) Avoidance and management of positive surgical margins before, during and after radical prostatectomy. Prostate Cancer Prostatic Dis 5(4):252-263
16. Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ (1989) The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13(1):21-27
17. Scardino P (2005) Update: NCCN prostate cancer clinical practice guidelines. J Natl Compr Canc Netw 3(Suppl 1):S29-S33
18. Middleton RG (1996) The management of clinically localized prostate cancer: Guidelines from the American Urological Association. CA Cancer J Clin 46(4):249-253
19. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, Van PH et al (2005) EAU guidelines on prostate cancer. Eur Urol 48(4):546-551
20. Klotz L (2006) Combined androgen blockade: An update. Urol Clin North Am 33(2):161-1vi
21. Klotz L (2005) Active surveillance for prostate cancer: For whom? J Clin Oncol 23(32):8165-8169
22. Albertsen PC, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293(17):2095-2101
23. Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A et al (2004) Natural history of early, localized prostate cancer. JAMA 291(22):2713-2719
24. Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML (2007) Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 178(5):1933-1937
25. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M et al (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347(11):781-789
26. Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C et al (2008) Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 100(16):1144-1154
27. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352(19):1977-1984
28. Johansson E, Bill-Axelson A, Holmberg L, Onelov E, Johansson JE, Steineck G (2008) Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: The randomized scandinavian prostate cancer group study number 4 (SPCG-4) clinical trial. Eur Urol [Epub ahead of print]
29. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591-1597
30. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90(10):766-771
31. Yossepowitch O, Eastham JA (2008) Radical prostatectomy for high-risk prostate cancer. World J Urol 26(3):219-224